Literature DB >> 22758388

Combined romiplostim and intravenous immunoglobulin therapy increased platelet count, facilitating splenectomy in a patient with refractory immune thrombocytopenic purpura unresponsive to monotherapy.

Kenjiro Mitsuhashi, Midori Ishiyama, Yoichi Imai, Masayuki Shiseki, Naoki Mori, Masanao Teramura, Akiyoshi Seshimo, Toshiko Motoji.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22758388     DOI： 10.1111/j.1365-2141.2012.09220.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Romiplostim as early treatment for refractory primary immune thrombocytopenia.

Authors:  Anne Contis; Estibaliz Lazaro; Carine Greib; Jean-Luc Pellegrin; Jean-François Viallard
Journal:  Int J Hematol       Date:  2013-09-26       Impact factor: 2.490

2.  Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice.

Authors:  Tomás José González-López; Fernando Fernández-Fuertes; José Angel Hernández-Rivas; Blanca Sánchez-González; Violeta Martínez-Robles; María Teresa Alvarez-Román; Gloria Pérez-Rus; Cristina Pascual; Silvia Bernat; Esther Arrieta-Cerdán; Carlos Aguilar; Abelardo Bárez; María Jesús Peñarrubia; Pavel Olivera; Angeles Fernández-Rodríguez; Erik de Cabo; Luis Javier García-Frade; José Ramón González-Porras
Journal:  Int J Hematol       Date:  2017-06-30       Impact factor: 2.490

Review 3.  Role of romiplostim in splenectomized and nonsplenectomized patients with immune thrombocytopenia.

Authors:  Jose Perdomo
Journal:  Immunotargets Ther       Date:  2016-02-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.